Plasfer announces the submission of an international patent application (PCT) aiming at strengthening the company’s intellectual property position in platelets-based therapeutics technologies for the delivery of genetic payloads in the treatment of pancreatic cancer.

EP2022/072484
Functionalized Platelets transfected with siRNA and their therapeutic uses. It describes a therapeutic composition comprising blood platelets transfected with siRNA directed against a mutant form of the KRAS oncoprotein, and its use for the treatment of pancreatic cancer.

(Full Press Release)